Detalhe da pesquisa
1.
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations.
BJU Int
; 2024 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403809
2.
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.
BMC Cancer
; 23(1): 605, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391708
3.
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset.
BJU Int
; 130(6): 754-763, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928524
4.
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer.
World J Urol
; 39(9): 3337-3344, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713162
5.
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
BJU Int
; 126(5): 625-632, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762064
6.
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
World J Urol
; 38(2): 381-388, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31020424
7.
A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
J Urol
; 202(5): 905-912, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31144594
8.
Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.
BJU Int
; 124(3): 449-456, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30950568
9.
Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods.
Anal Chem
; 90(9): 5841-5849, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624047
10.
Bladder cancer.
Lancet
; 388(10061): 2796-2810, 2016 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27345655
11.
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
J Urol
; 197(6): 1410-1418, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049011
12.
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
J Urol
; 197(3 Pt 1): 590-595, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746284
13.
Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.
BJU Int
; 117(6B): E102-13, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305667
14.
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.
BJU Int
; 118(1): 44-52, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26469362
15.
Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.
Future Oncol
; 12(8): 1025-38, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975197
16.
Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.
J Urol
; 194(6): 1575-81, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119672
17.
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus.
Urol Int
; 94(1): 1-24, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25501325
18.
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides.
Radiol Oncol
; 49(1): 50-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810701
19.
Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
Am J Pathol
; 182(2): 339-49, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201130
20.
5-Year outcome of a randomized prospective study comparing bacillus Calmette-Guérin with epirubicin and interferon-α2b in patients with T1 bladder cancer.
J Urol
; 191(5): 1244-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231843